Skip to content

Drug interactions

Dipyridamole + Talazoparib

Severity: Moderate

Dipyridamole and Talazoparib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dipyridamole inhibits BCRP and may increase talazoparib exposure, raising the risk of anemia and thrombocytopenia. The interaction is mechanism-based and not well characterized.

What this interaction means in plain words

Dipyridamole and Talazoparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dipyridamole belongs to Cardiovascular; Talazoparib belongs to Oncology.

Evidence level: Low

Why it happens

Dipyridamole inhibits BCRP-mediated efflux of talazoparib, potentially increasing its exposure.

What to do

Monitor blood counts and reduce the talazoparib dose if hematologic toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dipyridamole and Talazoparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dipyridamole with Talazoparib?

MediHelp rates the interaction as moderate. Dipyridamole and Talazoparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dipyridamole inhibits BCRP and may increase talazoparib exposure, raising the risk of anemia and thrombocytopenia. The interaction is mechanism-based and not well characterized.

How serious is the interaction between Dipyridamole and Talazoparib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and reduce the talazoparib dose if hematologic toxicity occurs.

What other medicines interact with Dipyridamole?

MediHelp also lists interactions of Dipyridamole with, for example, Riociguat, Adenosine, Betrixaban. The full list is on the Dipyridamole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in